Palla Pharma: Enters sale and leaseback of Coolaroo site

Palla Pharma Enters sale and leaseback of Coolaroo site

  • Palla Pharma (PAL) enters into a sale and leaseback agreement of its $33.1 million manufacturing site in Melbourne
  • Upon receiving funds for the Coolaroo location, the company made a gain of around $21 million
  • Palla retains acess to $5 million of undrawn capacity under its existing credit facility
  • The 18-month lease arrangement, with an option to extend for six months, allows continued site access
  • PallaPharma shares are in the green, up 2.6 per cent, trading at 40 cents at 2:08 pm AEDT
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

UK Banks Seek Alternatives to Visa and Mastercard Amid Concerns

Financial institutions explore options for payment processing independence.Highlights: UK banks are seeking alternatives to Visa and Mastercard.Concerns arise...

Emirates NBD Leads $31 Million Round in Real Estate Investment Platform

Emirates NBD funds real estate platform for enhanced investment opportunities.Highlights: Emirates NBD leads a $31 million funding round.Investment...

NatWest Highlights AI Benefits for Customers Amid Digital Shift

The bank reports improved services through enhanced AI technology.Highlights: NatWest reports AI implementation has enhanced customer experiences.The bank...

Lloyds Investigates Use of Staff Bank Data During Pay Talks

The bank is reviewing data usage amid negotiations with staff over pay.Highlights: Lloyds Banking Group is reviewing data...